3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Cholangiocarcinoma
4
Stomach Neoplasms
2
Rectal Neoplasms
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Biliary Tract Neoplasms
2
Adenocarcinoma Of Esophagus
2
Ovarian Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Disease Progression
1
Central Nervous System Neoplasms
1
Carcinoma, Hepatocellular
1
Bile Duct Neoplasms
1
Advanced Rectal Cancer
1
Interventions
pembrolizumab
18
Specimen Handling
17
Magnetic Resonance Spectroscopy
12
Biopsy
12
Paclitaxel
9
Carboplatin
8
Radiosurgery
7
Nivolumab
7
trastuzumab deruxtecan
6
Pemetrexed
6
Leucovorin
6
Irinotecan
6
Fulvestrant
6
Fluorouracil
6
Bevacizumab
6
palbociclib
5
Oxaliplatin
5
Letrozole
5
Gemcitabine
5
Cetuximab
5
Taxes
4
Cisplatin
4
Capecitabine
4
olaparib
3
enzalutamide
3
durvalumab
3
Ipilimumab
3
Docetaxel
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Folfox protocol
×
30 days
×
Clear all
No trials found.